3D Tissue Models Summit 2025

InSphero at the SLAS 2025

Join us at the SLAS 2025 in San Diego. This key event gathers professionals from the toxicology community to exchange insights, research, and innovations. We look forward to connecting with fellow attendees and engaging in valuable discussions. 

Discover all our activities that will be taking place during the ACT Annual Meeting 2024 in Austin, Texas from Sunday, November 17 to Wednesday, November 20. See you there! 

Meet our Team at the SLAS 2025

Jan Lichtenberg

Jan Lichtenberg, PhD

CEO and Co-Founder
Madhu Nag

Madhu Nag, PhD

Chief Scientific Officer
Olivier Frey

Olivier Frey, PhD

Chief Operating Officer & Chief Technology Officer

Frauke Greve, PhD

Senior Product Manager

Nils Goedecke, PhD

Product Owner

Our Booth at the SLAS 2025

Visit our booth #2623 and discover our Scalable, Reliable and Reproducible 3D In Vitro Technology designed to empower researchers and accelerate a new era of breakthrough therapies.

Posters at the SLAS 2025

Species-Specific Liver Microtissues: A Set of Microphysiological Systems to Assess Translational Hepatotoxicity in Drug Development

Date: Monday, 18 November, 2024 | 5:00 –  6:30 PM

Poster number: P405

Maria Vittoria Colombo, PhD

Scientist / Product Coordinator

Solutions Spotlight Presentation at the SLAS 2025

In Vitro Hepatotoxicity Assessment with the 3D InSight™ Liver Microtissue Platform

Date: Monday, 27  January, 2025 | 12:30 – 12:5o PM

Location: Level 2, Room 204

Presentation of the 3D InSight™ Liver microtissue platform, a versatile, scalable, and industry-compatible in vitro system, and of its uses for predictive, investigative, and translational hepatotoxicity assessment applications.

Bruno Filippi

Bruno Filippi, PhD

Vice President, Liver Safety

SLAS 2025 Resources

Toward Patient-Relevant DILI Testing: Integrating Intrinsic Liver Vulnerability with Systemic Metabolic Cues
Studying Fibrosis using 3D InSight Human MASH Microtissues Leveraging ZEISS Lattice Lightsheet 7 for 3D High-Content Analysis
Scalable Whole-Plate Calcium Imaging of Human iPSC-Derived Neural Spheroids for Drug Screening and Neurotoxicity Assessment
Non-Destructive Multiplexed Imaging of 3D Liver Microtissues for Multi-Modal DILI Assessment
Gri3D® Hydrogel Microcavity Plates
Gri3D® One Platform – Endless Possibilities
Selection Guide Akura™/Gri3D®
Multiparameter-based assays in 3D human liver microtissues: Towards multiplexed in vitro NAMs for drug-induced liver injury (DILI) assessment

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

Webinar registration

Fill in the form below to register

View resource

Fill in the form below to view this resource